Aarti Pharmalabs Limited (BOM:543748)
India · Delayed Price · Currency is INR 706.50
+30.40 (4.50%)
At close: Apr 21, 2026
Aarti Pharmalabs Market Cap
Aarti Pharmalabs has a market cap or net worth of 64.07 billion as of April 22, 2026. Its market cap has decreased by -5.24% in one year.
Market Cap
64.07B
Enterprise Value
70.26B
Revenue
18.01B
Ranking
n/a
PE Ratio
29.97
Stock Price
706.50
Market Cap Chart
Since January 30, 2023, Aarti Pharmalabs's market cap has increased from 26.12B to 64.07B, an increase of 145.25%. That is a compound annual growth rate of 32.08%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 21, 2026 | 64.07B | -6.06% |
| Dec 31, 2025 | 68.20B | 9.67% |
| Dec 31, 2024 | 62.19B | 36.04% |
| Dec 29, 2023 | 45.72B | 75.00% |
| Jan 30, 2023 | 26.12B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Rubicon Research | 148.09B |
| Jubilant Pharmova | 143.25B |
| Caplin Point Laboratories | 133.34B |
| CORONA Remedies | 103.87B |
| Viyash Scientific | 91.18B |
| Procter & Gamble Health | 83.35B |
| Sanofi India | 81.98B |
| FDC Limited | 58.61B |